Schrodinger

Schrodinger, Inc. It was registered in California in August 1990 in accordance with relevant laws. The company has developed a physics-based computing platform that can predict the key properties of molecules with high accuracy, so that high-quality and new molecules for drug development and material applications can be discovered more quickly at lower cost. Their software is used by biopharmaceuticals, industrial companies, academic institutions and government laboratories around the world. The company is a leading provider of computing software solutions for drug discovery. In addition to providing customers with a variety of software solutions, the company accelerates all stages of molecular discovery, design and optimization. They also use their platforms and capabilities to cover a wide range of disease targets and indications through a series of collaborative and wholly-owned drug discovery programs.